Patients who received transfusions had lower mean arterial pressures (86 vs 98 mmHg) and Hb levels (7.6 vs 11.2 g/dL), and had more chronic kidney disease (12% vs 6%) and malignancy (32% vs 22%) than nontransfused patients. The gene discussed is GSTM1; the disease is chronic kidney disease.